IFF reports strong Q2 FY25 performance with US$2.8B in net sales
This growth was driven mainly by key segments such as Food ingredients, Taste and Health & Biosciences.
USA – International Flavours & Fragrances (IFF) delivered a strong performance in the second quarter of fiscal year 2025, reporting net sales of approximately US$2.8 billion.
This figure represents a 4% decline on a reported basis compared to the same period the previous year.
This growth was driven mainly by key segments such as Food ingredients, Taste and Health & Biosciences, which delivered US$850 million, US$631 million and US$577 million, respectively.
IFF’s financial results surpassed market expectations, highlighted by a remarkable 256% year-over-year increase in net income to US$612 million.
Earnings per share stood at US$2.38, with an adjusted EPS of US$1.15 when excluding amortisation, both of which exceeded analyst estimates.
The adjusted operating EBITDA reached US$552 million, reflecting a 20% margin and showcasing the company’s improved profitability.
In terms of financial health, IFF made significant progress, reducing its net debt to credit-adjusted EBITDA ratio to 2.5 times, a key step toward its deleveraging goals.
Strategically, IFF continued reshaping its portfolio, including divesting its soy crush, concentrates, and lecithin business to better focus on higher-margin, value-added products.
Erik Fyrwald, CEO of IFF, emphasised that these results demonstrate strong execution and profitable revenue growth despite a challenging operating environment.
He stated, “IFF’s second-quarter results reflect the progress we are making to strengthen our business and advance our strategic agenda.”
“Our teams delivered top-line growth and improved profitability, driven by disciplined execution and a strong focus on productivity.”
The Scent segment reported sales of US$603 million, with currency-neutral comparable sales rising 1% driven by strong double-digit growth in Fine Fragrance and modest gains in Consumer Fragrance.
The Pharma Solutions segment achieved reported sales of US$103 million.
The company also authorised a new USD 500 million share repurchase program, signalling confidence in its long-term value creation strategy.
Management reaffirmed its full-year 2025 guidance, projecting sales between US$10.6 billion and US$10.9 billion, with adjusted operating EBITDA expected to range from US$2 billion to US$2.15 billion.
“We remain on track to deliver our 2025 commitments we outlined earlier this year, even as the operating environment has become more challenging,” added Erik.
“While we expect growth to moderate in the second half, we are confident in our ability to deliver profitable growth for the full year.”
Sign up to HERE receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on our WhatsApp channel for updates.
